THERAPEUTICS

BIOPHARMACEUTICALS

Biopharmaceutical products are manufactured in living organisms, often the animal/plant cells or the recombinant microorganisms like E. coli or yeast. Biopharmaceuticals are one of the growing business areas of the pharmaceutical and biotechnology industry sector in the recent years. With patent expiry of several blockbusters in the coming decades, the biosimilar market is expected to grow at a high CAGR.

Biosimilars are imitation products of biopharmaceuticals, which are approved after the patent period of the original active ingredient has expired. The active ingredients of biosimilars are always individual and not completely identical to the original or first biopharmaceutical, which are very expensive drugs. The currently higher costs of biologics represent a bottleneck and often play a decisive role in the battle against conventional chemical drugs. Therefore, there are biosimilars on the market. These follow-on preparations are usually much cheaper. Biosimilars are in great demand in the therapy of various diseases.

The innovative technology platform of Lorven Biologics touches this core issue, which is manifested in our existing portfolio of significantly cost-effective biosimilar products. As a service we offer our experience for your success! We advise you from development to market approval of biosimilar product of your choice.